"including ACT making an IND submission to the US FDA to commence clinical trials in humans using the technology, which ACT currently plans to do during the second half of 2009."
ACTC will not leave pink sheet status until SEC compliant with filings. Your guess is as good as mine.
Market Data 
Markets 
AI
